These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 32328155)
21. Action potential clamp and chloroquine sensitivity of mutant Kir2.1 channels responsible for variant 3 short QT syndrome. El Harchi A; McPate MJ; Zhang Yh; Zhang H; Hancox JC J Mol Cell Cardiol; 2009 Nov; 47(5):743-7. PubMed ID: 19285083 [TBL] [Abstract][Full Text] [Related]
22. The effect of myocardial action potential duration on cardiac pumping efficacy: a computational study. Jeong DU; Lim KM Biomed Eng Online; 2018 Jun; 17(1):79. PubMed ID: 29907152 [TBL] [Abstract][Full Text] [Related]
24. Up-regulation of the inward rectifier K+ current (I K1) in the mouse heart accelerates and stabilizes rotors. Noujaim SF; Pandit SV; Berenfeld O; Vikstrom K; Cerrone M; Mironov S; Zugermayr M; Lopatin AN; Jalife J J Physiol; 2007 Jan; 578(Pt 1):315-26. PubMed ID: 17095564 [TBL] [Abstract][Full Text] [Related]
25. Styrax blocks inward and outward current of Kir2.1 channel. Ren S; Pang C; Li J; Huang Y; Zhang S; Zhan Y; An H Channels (Austin); 2017 Jan; 11(1):46-54. PubMed ID: 27540685 [TBL] [Abstract][Full Text] [Related]
26. Computational analysis of the effect of KCNH2 L532P mutation on ventricular electromechanical behaviors. Heikhmakhtiar AK; Dusturia N; Lim KM J Electrocardiol; 2021; 66():24-32. PubMed ID: 33721574 [TBL] [Abstract][Full Text] [Related]
27. [Cardiac inwardly rectifying potassium channel and arrhythmias]. Wu BW; Liu QH; Zhang L Sheng Li Xue Bao; 2012 Dec; 64(6):751-7. PubMed ID: 23258341 [TBL] [Abstract][Full Text] [Related]
28. Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome). Tristani-Firouzi M; Jensen JL; Donaldson MR; Sansone V; Meola G; Hahn A; Bendahhou S; Kwiecinski H; Fidzianska A; Plaster N; Fu YH; Ptacek LJ; Tawil R J Clin Invest; 2002 Aug; 110(3):381-8. PubMed ID: 12163457 [TBL] [Abstract][Full Text] [Related]
29. Function, subcellular localization and assembly of a novel mutation of KCNJ2 in Andersen's syndrome. Hosaka Y; Hanawa H; Washizuka T; Chinushi M; Yamashita F; Yoshida T; Komura S; Watanabe H; Aizawa Y J Mol Cell Cardiol; 2003 Apr; 35(4):409-15. PubMed ID: 12689820 [TBL] [Abstract][Full Text] [Related]
30. Identification and functional characterisation of a novel KCNJ2 mutation, Val302del, causing Andersen-Tawil syndrome. Ördög B; Hategan L; Kovács M; Seprényi G; Kohajda Z; Nagy I; Hegedűs Z; Környei L; Jost N; Katona M; Szekeres M; Forster T; Papp JG; Varró A; Sepp R Can J Physiol Pharmacol; 2015 Jul; 93(7):569-75. PubMed ID: 26103554 [TBL] [Abstract][Full Text] [Related]
31. Andersen mutations of KCNJ2 suppress the native inward rectifier current IK1 in a dominant-negative fashion. Lange PS; Er F; Gassanov N; Hoppe UC Cardiovasc Res; 2003 Aug; 59(2):321-7. PubMed ID: 12909315 [TBL] [Abstract][Full Text] [Related]
32. In-silico human electro-mechanical ventricular modelling and simulation for drug-induced pro-arrhythmia and inotropic risk assessment. Margara F; Wang ZJ; Levrero-Florencio F; Santiago A; Vázquez M; Bueno-Orovio A; Rodriguez B Prog Biophys Mol Biol; 2021 Jan; 159():58-74. PubMed ID: 32710902 [TBL] [Abstract][Full Text] [Related]
33. Genotype-phenotype correlations of KCNJ2 mutations in Japanese patients with Andersen-Tawil syndrome. Haruna Y; Kobori A; Makiyama T; Yoshida H; Akao M; Doi T; Tsuji K; Ono S; Nishio Y; Shimizu W; Inoue T; Murakami T; Tsuboi N; Yamanouchi H; Ushinohama H; Nakamura Y; Yoshinaga M; Horigome H; Aizawa Y; Kita T; Horie M Hum Mutat; 2007 Feb; 28(2):208. PubMed ID: 17221872 [TBL] [Abstract][Full Text] [Related]
34. Loss-of-function mutations of the K(+) channel gene KCNJ2 constitute a rare cause of long QT syndrome. Fodstad H; Swan H; Auberson M; Gautschi I; Loffing J; Schild L; Kontula K J Mol Cell Cardiol; 2004 Aug; 37(2):593-602. PubMed ID: 15276028 [TBL] [Abstract][Full Text] [Related]
35. Modeling of IK1 mutations in human left ventricular myocytes and tissue. Seemann G; Sachse FB; Weiss DL; Ptácek LJ; Tristani-Firouzi M Am J Physiol Heart Circ Physiol; 2007 Jan; 292(1):H549-59. PubMed ID: 16936001 [TBL] [Abstract][Full Text] [Related]
36. Andersen-Tawil syndrome: a model of clinical variability, pleiotropy, and genetic heterogeneity. Donaldson MR; Yoon G; Fu YH; Ptacek LJ Ann Med; 2004; 36 Suppl 1():92-7. PubMed ID: 15176430 [TBL] [Abstract][Full Text] [Related]
37. Lack of any cardiac involvement in a patient with Andersen-Tawil syndrome associated with the c.574A→G mutation in KCNJ2. Modoni A; Bianchi ML; Vitulano N; Pagliarani S; Perna F; Sanna T; Rizzo V; Silvestri G Cardiology; 2011; 120(4):200-3. PubMed ID: 22286118 [TBL] [Abstract][Full Text] [Related]
39. Modelling the effects of chloroquine on Luo C; Wang K; Zhang H Oncotarget; 2017 Dec; 8(63):106511-106526. PubMed ID: 29290967 [TBL] [Abstract][Full Text] [Related]
40. Novel KCNJ2 mutation in familial periodic paralysis with ventricular dysrhythmia. Ai T; Fujiwara Y; Tsuji K; Otani H; Nakano S; Kubo Y; Horie M Circulation; 2002 Jun; 105(22):2592-4. PubMed ID: 12045162 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]